Advanced search
Publication Cover
Leukemia & Lymphoma Volume 50, 2009 - Issue 3
Submit an article Journal homepage
108
Views
4
CrossRef citations to date
0
Altmetric
Letters to the Editor

Is imatinib mesylate a promising drug in scleroderma due to extensive chronic graft-versus-host disease?

Vassilios Papadakis Department of Pediatric Hematology–Oncology, Agia Sofia Children's Hospital, Athens, GreeceCorrespondence[email protected]
,
Dimitri Karakasis Hematology and Lymphomas Department, Bone Marrow Transplantation Unit, Evangelismos Hospital, Athens, Greece
,
Petros P. Sfikakis First Department of Propedeutic and Internal Medicine, Laikon Hospital, Athens, Greece
,
Ioannis Baltadakis Hematology and Lymphomas Department, Bone Marrow Transplantation Unit, Evangelismos Hospital, Athens, Greece
,
John Apostolidis Hematology and Lymphomas Department, Bone Marrow Transplantation Unit, Evangelismos Hospital, Athens, Greece
,
Kostas Evangelou Department of Histology, Athens University Medical School, Athens, Greece
,
Vassilis G. Gorgoulis Department of Histology, Athens University Medical School, Athens, Greece
&
Nikolaos Harhalakis Hematology and Lymphomas Department, Bone Marrow Transplantation Unit, Evangelismos Hospital, Athens, Greece
 show all
Pages 471-474 | Received 29 Oct 2008, Accepted 04 Dec 2008, Published online: 01 Jul 2009

Citations (4)

Keep up to date with the latest research on this topic with citation updates for this article.

Subscribe to citation updates

Read on this site (1)

Pia Moinzadeh, Nicolas Hunzelmann & Thomas Krieg. (2013) Pharmacology and rationale for imatinib in the treatment of scleroderma. Journal of Experimental Pharmacology 5, pages 15-22.
Read now

Articles from other publishers (3)

Vasiliki-Kalliopi Bournia, Konstantinos Evangelou & Petros P. Sfikakis. (2013) Therapeutic Inhibition of Tyrosine Kinases in Systemic Sclerosis: A Review of Published Experience on the First 108 Patients Treated with Imatinib. Seminars in Arthritis and Rheumatism 42:4, pages 377-390.
Crossref
Hillard M. Lazarus, Lisa M. Arfons & Richard J. Creger. 2013. Neoplastic Diseases of the Blood. Neoplastic Diseases of the Blood 1321 1345 .
Michael J. Burke, Qing Cao, Barb Trotz, Brenda Weigel, Ashish Kumar, Angela Smith & Michael R. Verneris. (2009) Allogeneic hematopoietic cell transplantation (allogeneic HCT) for treatment of pediatric Philadelphia chromosome‐positive acute lymphoblastic leukemia (ALL). Pediatric Blood & Cancer 53:7, pages 1289-1294.
Crossref

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Order Reprints Request Corporate Permissions

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

Request Academic Permissions

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.

Related research

People also read lists articles that other readers of this article have read.

Recommended articles lists articles that we recommend and is powered by our AI driven recommendation engine.

Cited by lists all citing articles based on Crossref citations.
Articles with the Crossref icon will open in a new tab.